Patents by Inventor Raymund Wellinger

Raymund Wellinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions relating to hnRNP A1, A1B, A2, and B1 nucleic acid molecules
    Publication number: 20050153918
    Abstract: The present invention provides methods for inducing cell death using hnRNP A1, A1B, A2, and B1 nucleic acid molecules. The invention further provides therapeutic and diagnostic methods for neoplasia treatment relating to hnRNP A1, A1B, A2, and B1 nucleic acid molecules.
    Type: Application
    Filed: September 17, 2004
    Publication date: July 14, 2005
    Inventors: Benoit Chabot, Louise Bouchard, Pascale Labrecque, Caroline Patry, Raymund Wellinger
  • Methods for monitoring the binding of A1/UP1 to single-stranded nucleic acid sequences, and to measure the effect of this binding on telomere extension and protection
    Patent number: 6358687
    Abstract: The present invention relates to the length of telomeres and to their effect on proliferation and senescence in cells. More specifically, it concerns the ability of hnRNP A1 and its shortened derivative UP1 to alter the length of telomeres in cells. More precisely, the invention relates to the ability of A1/UP1 to bind telomerase RNA, to bind and to protect mammalian telomeric DNA, and to modulate telomere extension and replication. Finally, the present invention relates to agents which can interfere with the binding of A1/UP1 to telomeres and telomerase, and to the use of protection, extension and replication assays to measure the biological impact of these agents.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: March 19, 2002
    Assignee: Telogene Inc.
    Inventors: Benoit Chabot, Raymund Wellinger